首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >A clinical evaluation of amlexanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with amlexanox oral tablets: a randomized placebo controlled blinded multicenter clinical trial
【2h】

A clinical evaluation of amlexanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with amlexanox oral tablets: a randomized placebo controlled blinded multicenter clinical trial

机译:Amlexanox口腔粘膜防护膜治疗复发性口疮性口炎的临床评价以及与amlexanox口服片剂的比较:一项随机安慰剂对照双盲多中心临床试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAmlexanox has been developed as a 5 percent topical oral paste for the treatment of patients with recurrent aphthous stomatitis (RAS) in most European countries. However, it is not yet available in China and has not been generally accepted in clinical treatment. The aim of this study was to explore the effectiveness of amlexanox oral adhesive pellicles in the treatment of minor recurrent aphthous ulcers, and compare the results with those of amlexanox oral adhesive tablets in order to analyse the difference between the two dosage forms of amlexanox.
机译:背景在大多数欧洲国家/地区,Amlexanox已被开发为5%的局部口服糊剂,用于治疗复发性口疮性口炎(RAS)患者。但是,它在中国尚不可用,尚未在临床治疗中普遍接受。这项研究的目的是探讨氨甲ano呤口腔黏膜防护膜在治疗轻度复发性口疮中的有效性,并将其结果与氨甲ano呤口腔黏膜压片进行比较,以分析两种剂型之间的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号